| This week's sponsor is Premier Research. | | | Overcoming Risk in Oncology Drug Development
Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Click here for tips on finding the fast track. Premier Research. Built for biotech. |
Today's Rundown Adaptimmune CEO Noble to retire, CFO Rawcliffe steps up to the plate Carrick hires ex-Tesaro CFO, shifts focus toward U.S. Sierra doubles down on ex-Gilead drug, deprioritizes other assets [Sponsored] Frontage Holdings Corporation Celebrates a Successful Initial Public Offering on the HKEx Treating pancreatic cancer by starving tumor cells EuroBiotech Report—Sanifit bags €55M, LifeArc backs Kymab, Modag A round, Evotec and Verona FiercePharmaAsia—Daiichi, Glenmark FDA refusals; Takeda U.S. HQ move; JLABS Shanghai opening Chutes & Ladders—Frontier Medicines launches with biotech vet as CEO Featured Story | | | Thursday, June 27, 2019 Adaptimmune Chief Financial Officer Adrian Rawcliffe will take over in September when CEO and co-founder James Noble retires. The T-cell therapy specialist is now on the hunt for a new CFO. |
|
|
Top Stories Friday, June 28, 2019 Carrick Therapeutics is shifting its center of gravity toward the U.S. The Anglo-Irish cancer biotech has appointed ex-Tesaro CFO Tim Pearson to lead the company from its new site in Boston. Friday, June 28, 2019 Sierra Oncology is betting its future on the phase 3 myelofibrosis drug it picked up from Gilead for a knockdown price. The JAK 1/2 inhibitor underwhelmed in the clinic at Gilead but Sierra has decided to focus its resources on the drug, leading it to search for non-dilutive ways to fund other assets. Monday, June 24, 2019 Frontage is Growing to Meet All Your Needs! Thursday, June 27, 2019 A research team at Sanford Burnham Prebys Medical Discovery Institute has offered fresh insights into how to starve tumor cells of nutrients, pointing to a possible way of developing new drugs to treat pancreatic cancer. Thursday, June 27, 2019 In this week's EuroBiotech Report, Sanifit bags €55 million, LifeArc backs Kymab and Modag raises €12 million A round. Friday, June 28, 2019 The FDA rejected Daiichi Sankyo's blood cancer drug quizarinib and Glenmark's rhinitis nasal spray Ryaltris. Takeda set a deadline for its U.S. headquarters move from Chicago to Boston. JLABS launched a Shanghai chapter with 31 startups. And more. Friday, June 28, 2019 Frontier Medicines is launching with $67 million and a biotech vet as CEO; after being snapped up by Alexion, Syntimmune's CEO is joining MorphoSys; and Recursion has named a Theravance veteran as CSO. Those moves plus more hirings, firings and retirings throughout the industry. Resources Sponsored by: Titian Software This Essential Guide to Managing Laboratory Samples is a three-part piece exploring common problems experienced in the management of samples and how, for any scale of operation, significant efficiency and accuracy benefits can be gained using dedicated sample management software. Sponsored by: Elemental Machines How can the Internet of Things (IoT) enable you to meet GxP? Sponsored by: Veradigm Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities. Sponsored by: OCT Clinical Trials | June 20, 2019 | 2pm EDT / 11am PDT Fast and cost-efficient patient-enrollment,100% success strategy for obtaining a CTA, unified market authorization across the EEU countries. Find out the key compelling reasons to conduct studies in Russia. Sponsored by: AlphaSense What is agile competitive intelligence, and how can it help take market research to the next level? Sponsored by: Reprints Desk, Inc. Get 5 quick tips for faster research and better results! Sponsored by: Blue Latitude Health In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today. Download the report. Sponsored by: Patheon, by Thermo Fisher Scientific Increase Safety & Flexibility with Flow Chemistry Sponsored by: Veeva IONIS shares best practices for implementing an end-to-end RIM solution in this on-demand webinar. Watch now. Sponsored by: WCG Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register and start preparing Today! |
